,uuid,title,publisher,link,providerPublishTime,type
0,65842172-0a5f-3e11-a038-656470ec1425,AstraZeneca's (AZN) Imfinzi Misses Goal in Cervical Cancer Study,Zacks,https://finance.yahoo.com/news/astrazenecas-azn-imfinzi-misses-goal-182406237.html,1648232646,STORY
1,df796ce3-afad-3b23-be3d-d38a838d272d,Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) for Patients With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors in Five Different Types of Cancer,Business Wire,https://finance.yahoo.com/news/merck-receives-positive-eu-chmp-130000423.html,1648213200,STORY
2,ad2cfd54-1e02-32a7-baa8-d3faf50e0eb2,Addressing Health Equity in the Age of COVID-19,News Direct,https://finance.yahoo.com/news/addressing-health-equity-age-covid-125608378.html,1648212968,STORY
3,d3aaf1eb-f3ad-3471-903e-4ba46ab9ed39,"Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS ≥1)",Business Wire,https://finance.yahoo.com/news/merck-receives-positive-eu-chmp-125600777.html,1648212960,STORY
4,8e254227-1a81-3ec3-834e-c6e2bee95398,"Pharma Stock Roundup: NVS, MRK Get FDA Nod, PFE Ulcerative Colitis Study Succeeds",Zacks,https://finance.yahoo.com/news/pharma-stock-roundup-nvs-mrk-141402252.html,1648131242,STORY
5,8f019882-eb40-3124-8b55-9e43ef673de0,Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio,Zacks,https://finance.yahoo.com/news/why-1-growth-stock-could-142202657.html,1648045322,STORY
6,bdf071a8-ef51-3091-94b5-ce304cdb52cf,AstraZeneca's preventative COVID shot set to win EU clearance this week-sources,Reuters,https://finance.yahoo.com/news/astrazenecas-preventative-covid-shot-set-141649009.html,1648045009,STORY
7,38d78d30-9088-3188-8c0d-e3308b588cc2,4D Pharma Shares Soar On MRx0518/Keytruda Combo Trial Data In Renal Cell Carcinoma,Benzinga,https://finance.yahoo.com/news/4d-pharma-shares-soar-mrx0518-133034288.html,1648042234,STORY
